Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

RenovoRx Inc

RNXT
Current price
1.16 USD -0.02 USD (-1.69%)
Last closed 1.14 USD
ISIN US75989R1077
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 27 344 838 USD
Yield for 12 month +10.48 %
1Y
3Y
5Y
10Y
15Y
RNXT
21.11.2021 - 28.11.2021

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. Address: 4546 El Camino Real, Los Altos, CA, United States, 94022

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-6 000 USD

Current Quarter

Last Quarter

Key Figures RNXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 390 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -70.08 %
PEG Ratio
Return On Equity TTM -155.12 %
Wall Street Target Price 5.25 USD
Revenue TTM
Book Value 0.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.6 USD
Diluted Eps TTM -0.6 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics RNXT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RNXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation RNXT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -4.7228
Price Book MRQ 2.9492

Financials RNXT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RNXT

For 52 weeks

0.53 USD 2.35 USD
50 Day MA 1.03 USD
Shares Short Prior Month 114 311
200 Day MA 1.22 USD
Short Ratio 2.14
Shares Short 91 861
Short Percent 0.39 %